공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 의약품 수탁 개발 제조 기관(CMO) 시장 분석(2021년) : 코로나19(COVID-19)에 의한 성장과 변화(-2030년)

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2021: COVID-19 Growth And Change To 2030

리서치사 The Business Research Company
발행일 On Demand Report 상품 코드 1028801
페이지 정보 영문 175 Pages
가격
US $ 5,000 ₩ 5,987,000 PDF (Single User License)
US $ 7,500 ₩ 8,981,000 PDF (Site License)
US $ 10,000 ₩ 11,975,000 PDF (Enterprise License)


세계의 의약품 수탁 개발 제조 기관(CMO) 시장 분석(2021년) : 코로나19(COVID-19)에 의한 성장과 변화(-2030년) Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2021: COVID-19 Growth And Change To 2030
발행일 : On Demand Report 페이지 정보 : 영문 175 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 의약품 수탁 개발 제조 기관(CMO) 시장의 구조와 동향에 대해 분석했으며, 시장의 주요 특징과 구조, 전체적인 시장 규모·성장률 동향 전망, 유형별 및 지역별·주요 국가별 상세 동향, 주요 기업 개요, 최근의 주요 동향, 향후 시장 기회 등에 대해 전해드립니다.

목차

제1장 개요

제2장 의약품 수탁 개발 제조 기관(CMO) 시장의 특징

제3장 의약품 수탁 개발 제조 기관(CMO) 시장 동향과 전략

제4장 의약품 수탁 개발 제조 기관(CMO) 시장에 대한 코로나19(COVID-19)의 영향

제5장 의약품 수탁 개발 제조 기관(CMO) 시장 : 시장 규모 및 성장률

  • 시장 규모(단위 : 10억 달러, 2015-2020년)
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 시장 규모(단위 : 10억 달러, 2020-2025년, 2030년)
    • 시장 성장 촉진요인
    • 시장 성장 억제요인

제6장 의약품 수탁 개발 제조 기관(CMO) 시장 : 분야별 분석

  • 유형별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 원료의약품(API) 제조
  • 최종 제제(FDF) 개발/제조
  • 2차 포장
  • 임상시험 단계별(상별) 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 전임상
  • 1상
  • 2상
  • 3상
  • 4상

제7장 의약품 수탁 개발 제조 기관(CMO) 시장 : 지역별/국가별 분석

  • 지역별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 국가별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)

제8장 아시아태평양의 의약품 수탁 개발 제조 기관(CMO) 시장

  • 시장 개요
  • 지역 정보
  • 유형별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽의 의약품 수탁 개발 제조 기관(CMO) 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 동유럽의 의약품 수탁 개발 제조 기관(CMO) 시장

제20장 러시아 시장

제21장 북미의 의약품 수탁 개발 제조 기관(CMO) 시장

제22장 미국 시장

제23장 남미의 의약품 수탁 개발 제조 기관(CMO) 시장

제24장 브라질 시장

제25장 중동의 의약품 수탁 개발 제조 기관(CMO) 시장

제26장 아프리카의 의약품 수탁 개발 제조 기관(CMO) 시장

제27장 의약품 수탁 개발 제조 기관(CMO) 시장 : 경쟁 구도와 기업 개요

  • 경쟁 구도
  • 기업 개요
    • Recipharm AB
    • Pfizer Inc.
    • Catalent Pharma Solutions
    • Aenova Group
    • Famar

제28장 의약품 수탁 개발 제조 기관(CMO) 시장의 주요 인수합병(M&A)

제29장 의약품 수탁 개발 제조 기관(CMO) 시장 : 전망과 잠재력 분석

제30장 부록

LSH 21.09.30

“Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2021: COVID-19 Growth And Change to 2030” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global pharmaceutical contract development and manufacturing organization market.

This report focuses on the pharmaceutical contract development and manufacturing organization market which is experiencing strong growth. The report gives a guide to the pharmaceutical contract development and manufacturing organization market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the pharmaceutical contract development and manufacturing organization? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Pharmaceutical Contract Development And Manufacturing Organization market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical contract development and manufacturing organization market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The pharmaceutical contract development and manufacturing organization market section of the report gives context. It compares the pharmaceutical contract development and manufacturing organization market with other segments of the pharmaceutical contract development and manufacturing organization market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, pharmaceutical contract development and manufacturing organization indicators comparison.

Scope

Markets Covered:

1) By Type: Active Pharmaceutical Ingredient (API) Manufacturing; Finished Dosage Formulation (FDF) Development And Manufacturing; Secondary Packaging

2) By Research Phase: Preclinical; Phase I; Phase II; Phase III; Phase IV

Companies Mentioned: Recipharm AB; Pfizer Inc.; Catalent Pharma Solutions; Aenova Group; Famar

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Characteristics

3. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Trends And Strategies

4. Impact Of COVID-19 On Pharmaceutical Contract Development And Manufacturing Organization (CMO)

5. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Size And Growth

  • 5.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Segmentation

  • 6.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Active Pharmaceutical Ingredient (API) Manufacturing
  • Finished Dosage Formulation (FDF) Development And Manufacturing
  • Secondary Packaging
  • 6.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Preclinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

7. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Regional And Country Analysis

  • 7.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 8.1. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 9.1. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • 9.2. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 10.1. India Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 11.1. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 12.1. Australia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 13.1. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 14.1. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 15.1. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • 15.2. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 16.1. UK Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 17.1. Germany Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 18.3. France Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 19.1. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • 19.2. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 20.1. Russia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 21.1. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • 21.2. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 22.1. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • 22.2. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 23.1. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • 23.2. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 24.1. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 25.1. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • 25.2. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

  • 26.1. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
  • 26.2. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Competitive Landscape And Company Profiles

  • 27.1. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Competitive Landscape
  • 27.2. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Company Profiles
    • 27.2.1. Recipharm AB
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Pfizer Inc.
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Catalent Pharma Solutions
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Aenova Group
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Famar
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

29. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
Back to Top
전화 문의
F A Q